Immunome, Inc. (IMNM)

21.74 +0.24 (+1.12%) USD  |  NASDAQ  |  Feb 23, 14:34
More

Immunome Net Preferred Equity Issued (Purchased) (Quarterly)

Net Preferred Equity Issued (Purchased) (Quarterly) Chart

View Net Preferred Equity Issued (Purchased) (Quarterly) for IMNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Preferred Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Preferred Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Preferred Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Preferred Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Preferred Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Prelude Therapeutics, Inc. --
Eli Lilly & Co. --
Relay Therapeutics, Inc. --
Context Therapeutics, Inc. --
Moderna, Inc. --